Alcohol and tobacco together cause the most harm-by a large margin
OTTAWA – HEALTH – “Alcohol causes more substance use-related costs for Canadians than either tobacco or all other drugs combined. This is particularly the case when it comes to lost productivity due to premature deaths and disabling injuries,” says Dr Tim Stockwell, director of CISUR. “The alcohol industry has been extensively deregulated in Canada over the past decade. While we urgently need to address harms from opioid use, policymakers should not overlook critical policies needed to reduce harms from the legal substances we now take for granted.”
Substance use costs Canadian society $38.4 billion a year, or almost $1,100 for every person in Canada, according to a new study. Alcohol and tobacco use contributed over two thirds (70%) of these costs, with opioids ranked a distant third. These costs have been rising in recent years, especially for alcohol, opioids, and cannabis.
The Canadian Substance Use Costs and Harms study was produced by the Canadian Centre on Substance Use and Addiction (CCSA) and the University of Victoria’s Canadian Institute for Substance Use Research (CISUR). This comprehensive study examined the costs and harms associated with substance use. Estimates span four broad areas: health care, lost production, criminal justice, and other direct costs, and cover a broad range of substances including alcohol, tobacco, cannabis, opioids and central nervous system (CNS) depressants, cocaine and CNS stimulants, and other substances such as hallucinogens and inhalants. The study provides national, provincial and territorial estimates for the cost and harms of substance use between 2007 and 2014—the latest year for which comprehensive data was available.
Costs related to lost productivity amounted to $15.7 billion or 41 percent of the total, while healthcare costs were $11.1 billion or 29 percent of the total. The third highest contributor to total substance-related costs was criminal justice with a cost of $9.0 billion or 23 percent of the total.
“We are in a critical period for Canadian policy-making about substance use, given the opioid crisis and the impending legalization of cannabis. These data provide evidence we can use to develop and evaluate the success of such substance use policies,” says Dr. Matthew Young, senior research and policy analyst at CCSA and one of the principal investigators.
Drawing from a variety of national, provincial and territorial databases, the data will be updated annually to help inform decision-makers, policy advisors, and researchers. To view the full Canadian Substance Use Costs and Harms report, visit www.csuch.ca/en.
